Rsc Medicinal Chemistry

SCI SCIE

国际简称：RSC MED CHEM 参考译名：Rsc药物化学

主要研究方向：Multiple 非预警期刊

《Rsc药物化学》(Rsc Medicinal Chemistry)是一本由ROYAL SOC CHEMISTRY出版的以Multiple为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q2 JCR分区
369 年发文量
4.6 IF影响因子
未开放 是否OA
12 issues/year 出版周期
English 出版语言

Research and review articles in medicinal chemistry and related drug discovery science.

[ 查看全部 ]

投稿咨询加急咨询

Rsc Medicinal Chemistry期刊信息

ISSN：2632-8682
出版语言：English
是否OA：未开放
E-ISSN：2632-8682
出版地区：ENGLAND
是否预警：否
出版商：ROYAL SOC CHEMISTRY
出版周期：12 issues/year
开源占比：0.1803
Gold OA文章占比：28.86%
OA被引用占比：0.1443...
出版国人文章占比：0.07
出版撤稿占比：0
研究类文章占比：79.95%

Rsc Medicinal Chemistry CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

5.7

0.756

0.981

学科类别	分区	排名	百分位
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmaceutical Science	Q2	63 / 191	67%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Organic Chemistry	Q2	74 / 215	65%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Pharmacology	Q2	116 / 328	64%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Drug Discovery	Q2	65 / 161	59%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Biochemistry	Q2	189 / 448	57%
大类：Pharmacology, Toxicology and Pharmaceutics 小类：Molecular Medicine	Q2	90 / 179	50%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Rsc Medicinal Chemistry中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	BIOCHEMISTRY & MOLECULAR BIOLOGY 生化与分子生物学 CHEMISTRY, MEDICINAL 药物化学	3区 3区

Rsc Medicinal Chemistry JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q2	97 / 328	70.6
学科：CHEMISTRY, MEDICINAL	SCIE	Q2	22 / 72	70.1
学科：BIOCHEMISTRY & MOLECULAR BIOLOGY	SCIE	Q2	130 / 328	60.52
学科：CHEMISTRY, MEDICINAL	SCIE	Q2	33 / 72	54.86

Rsc Medicinal Chemistry历年数据统计

影响因子

中科院分区

Rsc Medicinal Chemistry中国学者发文选摘

1、Structure-activity optimization of N-arylindole GPR52 agonists for enhanced antipsychotic efficacy: design, synthesis, and pharmacological evaluatio
Author: Hu, Xiaojie; Gu, Qingshan; Xiong, Qiuyu; Chen, Donglei; Wu, Qingkun; Zheng, Lu

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. 17, Issue 3, pp. 1749-1757. DOI: 10.1039/d5md00944h
2、The dual functions of a nor-sesquiterpene-triazole derivative against influenza A viruses through the activation of the Nrf2/HO-1 signaling pathway and interaction with hemagglutini
Author: Zhou, Shaofen; Wei, Jingyan; Li, Shixin; Qiu, Jingnan; Ma, Shuaiqi; He, Jian

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. 17, Issue 3, pp. 1735-1748. DOI: 10.1039/d5md00841g
3、A halogenated pregnenolone analogue suppresses HepG2 proliferation and induces apoptosis via PPARγ regulatio
Author: Xu, Shi-Ying; Liu, Quan-Xing; Luo, Yan; Wu, Wu-He; Li, Qing; Liao, Shang-Gao; Ao, Jun-Li; Xu, Guo-Bo

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. 17, Issue 3, pp. 1493-1512. DOI: 10.1039/d5md01142f
4、Endoperoxide delivered singlet oxygen: the future of PDT, without light or oxyge
Author: Wang, Wanwan; Wang, Lei; Sun, Rensong; Qian, Xiao; Liu, Ziang; Akkaya, Engin U

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. 17, Issue 3, pp. 1729-1734. DOI: 10.1039/d5md00887e
5、Rational discovery of novel phenylindole-bisamide derivatives as potent P-glycoprotein inhibitors for cancer multidrug resistanc
Author: Yang, Zhikun; Han, Jiajia; Yang, Yanhong; Yang, Xue; Du, Yijing; Huang, Zimeng; Ying, Leyi; Yu, Xin; Hua, Yi; Wu, Qihao; Mou, Xiaozhou; Wang, Hong

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1039/d6md00030d
6、Hypoxia-triggered dichloroacetate delivery with effective reversal of cancer cell reprogrammin
Author: Sun, Rensong; Wang, Lei; Liu, Ziang; Wu, Hao; Wang, Wanwan; Wang, Yang; Qian, Xiao; Akkaya, Engin U

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1039/d5md00911a
7、Discovery of novel BCAT2 inhibitors: design, synthesis, in vitro evaluation, and molecular modeling studie
Author: Xu, Dong; Weng, Wenxiu; Cao, Huining; Zhang, Chao; Zhang, Yudi; Li, Yan; Xiao, Junhai; Xie, Hua; Guo, Jialin; Chen, Guoliang

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1039/d6md00019c
8、Design, synthesis, and biological evaluation of quinoline derivatives as dual-target inhibitors of chitin synthase and glucosamine-6-phosphate synthas
Author: Wang, Nan; Liu, Lige; Liu, Tao; Luo, Hong; Long, Yan; Yang, Xinlong; Zhang, Youli; Ji, Qinggang

Journal: RSC MEDICINAL CHEMISTRY. 2026; Vol. , Issue , pp. -. DOI: 10.1039/d5md01001b